Cancer Informatics Collaboratory
Home / Datasets / ICBP43 breast cancer cell lines
Dataset · Breast cancer cell lines · Genomics and proteomics

ICBP43 Breast Cancer Cell Line Panel: Integrative Genomic Data

Six files on a panel of 43 breast cancer cell lines: protein response to the drug lapatinib over time, SNP genotypes and copy-number changes, with sample annotations to tie them together.

The research behind this page

  • Joe Gray and Jonathan Bistline: Lawrence Berkeley National Laboratory and Broad Institute (as listed).

These researchers created the original work. They did not write or review this page. ✓ marks a credential or role confirmed on an official profile; "as listed" roles come from the original page. All researchers featured on this site.

Based on: 1 peer-reviewed paper, 1 official project or publisher site, 1 archived original page. See all sources

Get the data

Producer
Lawrence Berkeley National Laboratory, exported from the Broad Institute ICBP portal
Released
13 Nov 2014
Cell lines
ICBP43 panel: 43 breast cancer cell lines
Data types
RPPA time course (lapatinib), Affymetrix SNP, segmented copy number (SNP6), annotations
Availability
The hub copy is gone. The cell lines are documented in Cellosaurus; the panel paper is open access.
Links checked 21 Nov 2026.

The six files

  • Reverse-phase protein lysate array (RPPA) time course after lapatinib treatment, plus a readme
  • Affymetrix SNP data for the panel
  • Segmented copy-number data (SNP6), plus a readme
  • Cell line sample annotations[1]

What you can use it for

  • Compare protein-level response to lapatinib, an HER2/EGFR inhibitor, across many breast cancer lines.
  • Link response to copy-number changes in the same lines.
  • Pick cell lines for a new experiment using the shared annotations.

Limit: the hub copy of the files was not archived, so check the original authors or the Broad ICBP portal history before relying on specific values.

About the cell line panel

The panel grew out of a large collection of breast cancer cell lines described by Neve and colleagues in 2006, which showed that cell lines keep many of the molecular subtypes seen in tumours. That is what makes a panel like this useful for testing drugs before work in patients.[2][3]

Key publications

  1. 2006Neve RM, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006.
    DOI: 10.1016/j.ccr.2006.10.008 · PubMed 17157791 · Free full text (PMC)

Identifiers checked against PubMed and the publishers' DOI records, 22 Nov 2026.

Sources

  1. Archived copy of the original page (26 Oct 2015) · web.archive.org · Archived original
  2. Neve et al. 2006, Cancer Cell (PMC) · pmc.ncbi.nlm.nih.gov · Research paper
  3. Cellosaurus · www.cellosaurus.org · Official site

About this page

This was a dataset page on the hub, released in November 2014 by Joe Gray and Jonathan Bistline. We rewrote it to describe the files and point to where the cell lines and the panel paper can be found today.